

These medications directly inhibit the blood’s ability to form blood clots.ĭOACs are both rapid and short-acting agents with relatively low bleeding risks and good overall safety profiles. Unlike warfarin these drugs do not require regular blood monitoring. Several direct oral anticoagulants (DOACs) have been approved by the United States Food & Drug Administration (FDA) since 2010. Home / About Clots / Blood Clot Treatment / Direct Oral Anticoagulants (DOACs) Direct Oral Anticoagulants (DOACs)

Panel Discussion: Blood Clots & Women’s Health.Helping Women Make Choices About Contraception Following DVT Blood Clots.

Frequently Asked Questions: COVID-19 and Blood Clotting.Managing Anticoagulants Before, During, and After Medical Procedures.Study Results Demonstrate VTE Treatment Satisfaction Among Patients.
